Ciprofloxacin Dosing for Morganella Bacteremia
For Morganella bacteremia in adults with normal renal function, administer ciprofloxacin 400 mg IV every 8 hours; for patients with creatinine clearance <30 mL/min, reduce to 400 mg IV every 24 hours. 1
Standard Dosing in Normal Renal Function
For serious infections like bacteremia, the FDA-approved regimen is 400 mg IV every 8 hours, which produces an AUC equivalent to 750 mg oral every 12 hours 1. This higher-intensity regimen is appropriate for bloodstream infections where achieving adequate drug exposure is critical for bacterial eradication.
- Each 400 mg IV dose infused over 60 minutes achieves a Cmax of approximately 4.07 mcg/mL
- The serum elimination half-life is 5-6 hours with total clearance around 35 L/hr
- Approximately 50-70% is excreted unchanged in urine 1
Renal Dose Adjustments
The dosing algorithm based on creatinine clearance (CrCl) is:
- CrCl >60 mL/min: 400 mg IV every 8 hours (standard dosing)
- CrCl 31-60 mL/min: 400 mg IV every 12 hours 2
- CrCl ≤30 mL/min: 400 mg IV every 24 hours 2
Evidence Supporting Renal Adjustments
Research demonstrates that ciprofloxacin clearance correlates directly with creatinine clearance (r² = 0.78), with renal clearance accounting for approximately 22 L/hr 2. In patients with severe renal impairment (CrCl <30 mL/min), the AUC increases significantly—approximately 4-fold compared to normal renal function—and the elimination half-life can prolong to 11-13 hours 3, 4.
Critical point: Modeling studies show that 400 mg every 24 hours in patients with CrCl ≤30 mL/min provides plasma concentrations similar to those achieved with 400 mg every 8 hours in patients with normal renal function 2.
Interval Extension vs. Dose Reduction
When adjusting for renal impairment, extend the dosing interval rather than reducing the individual dose. Pharmacodynamic modeling demonstrates that interval prolongation (e.g., 500 mg every 24 hours) achieves bacterial eradication by day 3, whereas dose reduction (e.g., 250 mg every 12 hours) delays eradication until day 6 5. This is because ciprofloxacin exhibits concentration-dependent killing, making peak concentrations more important than maintaining continuous levels.
Clinical Context for Morganella
Morganella morganii bacteremia carries a 41% in-hospital mortality rate, with increased risk in ICU patients and those >65 years 6. While M. morganii shows variable resistance patterns, ciprofloxacin remains a treatment option when susceptibility is confirmed. Always obtain susceptibility testing, as resistance to ciprofloxacin has been documented in clinical isolates 6.
Common Pitfalls
- Avoid under-dosing in normal renal function: The 400 mg every 12 hours regimen is insufficient for serious infections; use every 8-hour dosing
- Don't forget to adjust for elderly patients: While no specific dose reduction is required for age alone, elderly patients often have reduced renal function that necessitates adjustment 1
- Monitor for accumulation: In patients with CrCl <50 mL/min, the AUC doubles and renal clearance decreases to one-fourth of normal 4